Recent studies have shown that subpopulations of neoantigen-reactive CD8+ and CD4+ tumor infiltrating lymphocytes (TILs) have a Trm phenotype and are highly prognostic for patients with HNSCC and other cancer types (11, 12). This evidence concerns the gene CD4 and neoplasm.